Product
Tirolizumab+SOX/XELOX
1 clinical trial
4 indications
Indication
Gastric CarcinomaIndication
HER2 NegativeIndication
efficacyIndication
SafetyClinical trial
Clinical Efficacy and Safety of Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Resectable Gastric CancerStatus: Recruiting, Estimated PCD: 2025-04-30